Brain inflammation and epilepsy

Epilepsy: Mechanisms, Models, and Translational Perspectives

Volumn , Issue , 2010, Pages 45-59

  Ravizza, Teresa ^a   Balosso, Silvia ^a   Aronica, Eleonora ^b   Vezzani, Annamaria ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84888377309     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420085594     Document Type: Chapter

References (102)

1. Akassoglou, K., L. Probert, G. Kontogeorgos, G. Kollias. (1997). Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol., 158(1):438-445.
2. Allan, S.M., P.J. Tyrrell, N.J. Rothwell. (2005). Interleukin-1 and neuronal injury. Nat. Rev. Immunol., 5(8):629-640.
3. Aronica, E., K. Boer, E.A. van Vliet, S. Redeker, J.C. Baayen, W.G. Spliet, P.C. van Rijen, D. Troost, F.H. da Silva, W.J. Wadman, J.A. Gorter. (2007). Complement activation in experimental and human temporal lobe epilepsy. Neurobiol. Dis., 26(3):497-511.
4. Baik, E.J., E.J. Kim, S.H. Lee, C. Moon. (1999). Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res., 843(1-2):118-129.
5. Balosso, S., T. Ravizza, C. Perego, J. Peschon, I.L. Campbell, M.G. De Simoni, A. Vezzani. (2005). Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann. Neurol., 57(6):804-812.
6. Balosso, S., M. Maroso, M. Sanchez-Alavez, T. Ravizza, A. Frasca, T. Bartfai, A. Vezzani. (2008). A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain, 131(Pt. 12):3256-3265.
7. Barnum, S.R. (1995). Complement biosynthesis in the central nervous system. Crit. Rev. Oral Biol. Med., 6(2):132-146.
8. Beattie, E.C., D. Stellwagen, W. Morishita, J.C. Bresnahan, B.K. Ha, M. Von Zastrow, M.S. Beattie, R.C. Malenka. (2002). Control of synaptic strength by glial TNFalpha. Science, 295(5563):2282-2285.
9. Bernardino, L., S. Xapelli, A.P. Silva, B. Jakobsen, F.R. Poulsen, C.R. Oliveira, A. Vezzani, J.O. Malva, J. Zimmer. (2005). Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J. Neurosci., 25(29):6734-6744.
10. Bezzi, P., M. Domercq, L. Brambilla, R. Galli, D. Schols, E. De Clercq, A. Vescovi, G. Bagetta, G. Kollias, J. Meldolesi, A. Volterra. (2001). CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci., 4(7):702-710.
11. Bien, C.G., J. Bauer, T.L. Deckwerth, H. Wiendl, M. Deckert, O.D. Wiestler, J. Schramm, C.E. Elger, H. Lassmann. (2002). Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen’s encephalitis. Ann. Neurol., 51(3):311-318.
12. Boer, K., W.G. Spliet, P.C. van Rijen, S. Redeker, D. Troost, E. Aronica. (2006). Evidence of activated microglia in focal cortical dysplasia. J. Neuroimmunol., 173(1-2):188-195.
13. Boer, K., F. Jansen, M. Nellist, S. Redeker, A.M. van den Ouweland, W.G. Spliet, O. van Nieuwenhuizen, D. Troost, P.B. Crino, E. Aronica. (2008). Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res., 78(1):7-21.
14. Campbell, I.L., C.R. Abraham, E. Masliah, P. Kemper, J.D. Inglis, M.B. Oldstone, L. Mucke. (1993). Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U.S.A., 90(21):10061-10065.
15. Casamenti, F., C. Prosperi, C. Scali, L. Giovannelli, M.A. Colivicchi, M.S. Faussone-Pellegrini, G. Pepeu. (1999). Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer’s disease. Neuroscience, 91(3):831-842.
16. Chen, C., N.G. Bazan. (2005). Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediat., 77(1-4):65-76.
17. Chen, J., T. Marsh, J.S. Zhang, S.H. Graham. (1995). Expression of cyclo-oxygenase 2 in rat brain following kainate treatment. NeuroReport, 6(2):245-248.
18. Choi, J.S., S.Y. Kim, H.J. Park, J.H. Cha, Y.S. Choi, J.E. Kang, J.W. Chung, M.H. Chun, M.Y. Lee. (2003). Upregulation of gp130 and differential activation of STAT and p42/44 MAPK in the rat hippocampus following kainic acid-induced seizures. Brain Res. Mol. Brain Res., 119(1):10-18.
19. Cole-Edwards, K.K., N.G. Bazan. (2005). Lipid signaling in experimental epilepsy. Neurochem. Res., 30(6-7):847-853.
20. Crespel, A., P. Coubes, M.C. Rousset, C. Brana, A. Rougier, G. Rondouin, J. Bockaert, M. Baldy-Moulinier, M. Lerner-Natoli. (2002). Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res., 952(2):159-169.
21. Dawson, V.L., T.M. Dawson, E.D. London, D.S. Bredt, S.H. Snyder. (1991). Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A., 88(14):6368-6371.
22. De Luca, G., R.M. Di Giorgio, S. Macaione, P.R. Calpona, S. Costantino, E.D. Di Paola, A. De Sarro, G. Ciliberto, G. De Sarro. (2004). Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice. Pharmacol. Biochem. Behav., 78(1):75-81.
23. De Sarro, G., E. Russo, G. Ferreri, B. Giuseppe, M.A. Flocco, E.D. Di Paola, A. De Sarro. (2004). Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice. Pharmacol. Biochem. Behav., 77(4):761-766.
24. De Simoni, M.G., C. Perego, T. Ravizza, D. Moneta, M. Conti, F. Marchesi, A. De Luigi, S. Garattini, A. Vezzani. (2000). Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci., 12(7):2623-2633.
25. Desjardins, P., A. Sauvageau, A. Bouthillier, D. Navarro, A.S. Hazell, C. Rose, R.F. Butterworth. (2003). Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis. Neurochem. Int., 42(4):299-303.
26. Dinarello, C.A. (1996). Biologic basis for interleukin-1 in disease. Blood, 87(6):2095-2147.
27. Ding, S., T. Fellin, Y. Zhu, S.Y. Lee, Y.P. Auberson, D.F. Meaney, D.A. Coulter, G. Carmignoto, P.G. Haydon. (2007). Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus. J. Neurosci., 27(40):10674-10684.
28. Dubé, C., A. Vezzani, M. Behrens, T. Bartfai, T.Z. Baram. (2005). Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann. Neurol., 57(1):152-155.
29. Fabene, P.F., G. Navarro Mora, M. Martinello, B. Rossi, F. Merigo et al. (2008). A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med., 14(12):1377-1383.
30. Fellin, T., M. Gomez-Gonzalo, S. Gobbo, G. Carmignoto, P.G. Haydon. (2006). Astrocytic glutamate is not necessary for the generation of epileptiform neuronal activity in hippocampal slices. J. Neurosci., 26(36):9312-9322.
31. Fukuda, M., T. Morimoto, Y. Suzuki, C. Shinonaga, Y. Ishida. (2007). Interleukin-6 attenuates hyperthermiainduced seizures in developing rats. Brain Dev., 29(10):644-648.
32. Galic, M.A., K. Riazi, J.G. Heida, A. Mouihate, N.M. Fournier, S.J. Spencer, L.E. Kalynchuk, G.C. Teskey, Q.J. Pittman. (2008). Postnatal inflammation increases seizure susceptibility in adult rats. J. Neurosci., 28(27):6904-6913.
33. Gorter, J.A., E.A. van Vliet, E. Aronica, T. Breit, H. Rauwerda, F.H. Lopes da Silva, W.J. Wadman. (2006). Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J. Neurosci., 26(43):11083-11110.
34. Heida, J.G., Q.J. Pittman. (2005). Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia, 46(12):1906-1913.
35. Hewett, S.J., T.F. Uliasz, A.S. Vidwans, J.A. Hewett. (2000). Cyclooxygenase-2 contributes to N-methyld- aspartate-mediated neuronal cell death in primary cortical cell culture. J. Pharmacol. Exp. Ther., 293(2):417-425.
36. Hirst, W.D., K.A. Young, R. Newton, V.C. Allport, D.R. Marriott, G.P. Wilkin. (1999). Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol. Cell Neurosci., 13(1):57-68.
37. Holtman L., E.A. van Vliet, R. van Schaik, C.M. Queiroz, E. Aronica, J.A. Gorter. (2009). Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Res., 84(1):56-66.
38. Hu, S., W.S. Sheng, L.C. Ehrlich, P.K. Peterson, C.C. Chao. (2000). Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation, 7(3):153-159.
39. Hurley, S.D., J.A. Olschowka, M.K. O’Banion. (2002). Cyclooxygenase inhibition as a strategy to ameliorate brain injury. J. Neurotrauma, 19(1):1-15.
40. Jung, K.H., K. Chu, S.T. Lee, J. Kim, D.I. Sinn, J.M. Kim, D.K. Park, J.J. Lee, S.U. Kim, M. Kim, S.K. Lee, J.K. Roh. (2006). Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol. Dis., 23(2):237-246.
41. Kelley, K.A., L. Ho, D. Winger, J. Freire-Moar, C.B. Borelli, P.S. Aisen, G.M. Pasinetti. (1999). Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol., 155(3):995-1004.
42. Kim, H.J., J.I. Chung, S.H. Lee, Y.S. Jung, C.H. Moon, E.J. Baik. (2008). Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors. Brain Res., 1193:153-161.
43. Kovacs, Z., K.A. Kekesi, N. Szilagyi, I. Abraham, D. Szekacs, N. Kiraly, E. Papp, I. Csaszar, E. Szego, K. Barabas, H. Peterfy, A. Erdei, T. Bartfai, G. Juhasz. (2006). Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats. Neuroscience, 140(2):731-742.
44. Kunz, T., E.H. Oliw. (2001). The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur. J. Neurosci., 13(3):569-575.
45. Lee, B., H. Dziema, K.H. Lee, Y.S. Choi, K. Obrietan. (2007). CRE-mediated transcription and COX-2 expression in the pilocarpine model of status epilepticus. Neurobiol. Dis., 25(1):80-91.
46. Lee, S.H., S.H. Han, K.W. Lee. (2000). Kainic acid-induced seizures cause neuronal death in infant rats pretreated with lipopolysaccharide. NeuroReport, 11(3):507-510.
47. Lehtimaki, K.A., J. Peltola, E. Koskikallio, T. Keranen, J. Honkaniemi. (2003). Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain Res. Mol. Brain Res., 110(2):253-260.
48. Lehtimaki, K.A., T. Keranen, H. Huhtala, M. Hurme, J. Ollikainen, J. Honkaniemi, J. Palmio, J. Peltola. (2004). Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J. Neuroimmunol., 152(1-2):121-125.
49. Librizzi, L., M.C. Regondi, C. Pastori, S. Frigerio, C. Frassoni, M. de Curtis. (2007). Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro. Epilepsia, 48(4):743-751.
50. Lu, M.O., X.M. Zhang, E. Mix, H.C. Quezada, T. Jin, J. Zhu, A. Adem. (2008). TNF-alpha receptor 1 deficiency enhances kainic acid-induced hippocampal injury in mice. J. Neurosci. Res., 86(7):1608-1614.
51. Lucas, S.M., N.J. Rothwell, R.M. Gibson. (2006). The role of inflammation in CNS injury and disease. Br. J. Pharmacol., 147(Suppl. 1):S232-S240.
52. Maldonado, M., M. Baybis, D. Newman, D.L. Kolson, W. Chen, G. McKhann, 2nd, D.H. Gutmann, P.B. Crino. (2003). Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol. Dis., 14(2):279-290.
53. Marchi, N., L. Angelov, T. Masaryk, V. Fazio, T. Granata, N. Hernandez, K. Hallene, T. Diglaw, L. Franic, I. Najm, D. Janigro. (2007). Seizure-promoting effect of blood-brain barrier disruption. Epilepsia, 48(4):732-742.
54. Marchi, N., Q. Fan, C. Ghosh, V. Fazio, F. Bertolini, G. Betto, A. Batra, E. Carlton, I. Najm, T. Granata, D. Janigro. (2009). Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol. Dis., 33(2):171-181.
55. Minghetti, L. (2007). Role of COX-2 in inflammatory and degenerative brain diseases. Subcell. Biochem., 42:127-141.
56. Morgan, B.P., P. Gasque. (1996). Expression of complement in the brain: role in health and disease. Immunol. Today, 17(10):461-466.
57. Naffah-Mazzacoratti, M.G., M.I. Bellissimo, E.A. Cavalheiro. (1995). Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy. Neurochem. Int., 27(6):461-466.
58. Nakayama, M., K. Uchimura, R.L. Zhu, T. Nagayama, M.E. Rose, R.A. Stetler, P.C. Isakson, J. Chen, S.H. Graham. (1998). Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc. Natl. Acad. Sci. U.S.A., 95(18):10954-10959.
59. Okada, K., U. Yamashita, S. Tsuji. (2006). Cyclooxygenase system contributes to the maintenance of post convulsive period of epileptic phenomena in the genetically epileptic EL mice. J. Uoeh., 28(3):265-275.
60. Oliveira, M.S., A.F. Furian, L.F. Royes, M.R. Fighera, N.G. Fiorenza, M. Castelli, P. Machado, D. Bohrer, M. Veiga, J. Ferreira, E.A. Cavalheiro, C.F. Mello. (2008). Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures. Epilepsy Res., 79(1):14-21.
61. Peltola, J., J. Laaksonen, A.M. Haapala, M. Hurme, S. Rainesalo, T. Keranen. (2002). Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure, 11(1):44-46.
62. Plata-Salaman, C.R., S.E. Ilyin, N.P. Turrin, D. Gayle, M.C. Flynn, A.E. Romanovitch, M.E. Kelly, Y. Bureau, H. Anisman, D.C. McIntyre. (2000). Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res. Mol. Brain Res., 75(2):248-258.
63. Ravizza, T., A. Vezzani. (2006). Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience, 137(1):301-308.
64. Ravizza, T., K. Boer, S. Redeker, W.G. Spliet, P.C. van Rijen, D. Troost, A. Vezzani, E. Aronica. (2006a). The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol. Dis., 24(1):128-143.
65. Ravizza, T., S.M. Lucas, S. Balosso, L. Bernardino, G. Ku, F. Noe, J. Malva, J.C. Randle, S. Allan, A. Vezzani. (2006b). Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia, 47(7):1160-1168.
66. Ravizza, T., B. Gagliardi, F. Noe, K. Boer, E. Aronica, A. Vezzani. (2008a). Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis., 29(1):142-160.
67. Ravizza, T., F. Noe, D. Zardoni, V. Vaghi, M. Sifringer, A. Vezzani. (2008b). Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol. Dis., 31(3):327-333.
68. Riazi, K., M.A. Galic, J.B. Kuzmiski, W. Ho, K.A. Sharkey, Q.J. Pittman. (2008). Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc. Natl. Acad. Sci. U.S.A., 105(44):17151-17156.
69. Rigau, V., M. Morin, M.C. Rousset, F. de Bock, A. Lebrun, P. Coubes, M.C. Picot, M. Baldy-Moulinier, J. Bockaert, A. Crespel, M. Lerner-Natoli. (2007). Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain, 130(Pt. 7):1942-1956.
70. Rizzi, M., C. Perego, M. Aliprandi, C. Richichi, T. Ravizza, D. Colella, J. Veliskova, S.L. Moshe, M.G. De Simoni, A. Vezzani. (2003). Glia activation and cytokine increase in rat hippocampus by kainic acidinduced status epilepticus during postnatal development. Neurobiol. Dis., 14(3):494-503.
71. Rodgers, K.M., M.R. Hutchinson, A. Northcutt, S.F. Maier, L.R. Watkins, D.S. Barth. (2009). The cortical innate immune response increases local neuronal excitability leading to seizures. Brain, 132(9):2478-2486.
72. Rozovsky, I., T.E. Morgan, D.A. Willoughby, M.M. Dugichi-Djordjevich, G.M. Pasinetti, S.A. Johnson, C.E. Finch. (1994). Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience, 62(3):741-758.
73. Samland, H., S. Huitron-Resendiz, E. Masliah, J. Criado, S.J. Henriksen, I.L. Campbell. (2003). Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J. Neurosci. Res., 73(2):176-187.
74. Sandhya, T.L., W.Y. Ong, L.A. Horrocks, A.A. Farooqui. (1998). A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions. Brain Res., 788(1-2):223-231.
75. Sankar, R., S. Auvin, A. Mazarati, D. Shin. (2007). Inflammation contributes to seizure-induced hippocampal injury in the neonatal rat brain. Acta Neurol. Scand., 186(Suppl. 4):16-20.
76. Sayyah, M., M. Javad-Pour, M. Ghazi-Khansari. (2003). The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins. Neuroscience, 122(4):1073-1080.
77. Seibert, K., J.L. Masferrer. (1994). Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor, 4(1):17-23.
78. Seiffert, E., J.P. Dreier, S. Ivens, I. Bechmann, O. Tomkins, U. Heinemann, A. Friedman. (2004). Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci., 24(36):7829-7836.
79. Shinoda, S., S.L. Skradski, T. Araki, C.K. Schindler, R. Meller, J.Q. Lan, W. Taki, R.P. Simon, D.C. Henshall. (2003). Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur. J. Neurosci., 17(10):2065-2076.
80. Slanina, K.A., P. Schweitzer. (2005). Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus. Neuropharmacology, 49(5):653-659.
81. Stellwagen, D., E.C. Beattie, J.Y. Seo, R.C. Malenka. (2005). Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci., 25(12):3219-3228.
82. Takemiya, T., K. Suzuki, H. Sugiura, S. Yasuda, K. Yamagata, Y. Kawakami, E. Maru. (2003). Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Other Lipid Mediat., 71(3-4):205-216.
83. Takemiya, T., M. Maehara, K. Matsumura, S. Yasuda, H. Sugiura, K. Yamagata. (2006). Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region. Neurosci. Res., 56(1):103-110.
84. Tian, G.F., H. Azmi, T. Takano, Q. Xu, W. Peng, J. Lin, N. Oberheim, N. Lou, X. Wang, H.R. Zielke, J. Kang, M. Nedergaard. (2005). An astrocytic basis of epilepsy. Nat. Med., 11(9):973-981.
85. Tu, B., N.G. Bazan. (2003). Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp. Neurol., 179(2):167-175.
86. Turrin, N.P., S. Rivest. (2004). Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol. Dis., 16(2):321-334.
87. van Vliet, E.A., S. da Costa Araujo, S. Redeker, R. van Schaik, E. Aronica, J.A. Gorter. (2007). Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain, 130(Pt. 2):521-534.
88. Vezzani, A., T.Z. Baram. (2007). New roles for interleukin-1beta in the mechanisms of epilepsy. Epilepsy Curr., 7(2):45-50.
89. Vezzani, A., T. Granata. (2005). Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia, 46(11):1724-1743.
90. Vezzani, A., M. Conti, A. De Luigi, T. Ravizza, D. Moneta, F. Marchesi, M.G. De Simoni. (1999). Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application:functional evidence for enhancement of electrographic seizures. J. Neurosci., 19(12):5054-5065.
91. Vezzani, A., D. Moneta, M. Conti, C. Richichi, T. Ravizza, A. De Luigi, M.G. De Simoni, G. Sperk, S. Andell-Jonsson, J. Lundkvist, K. Iverfeldt, T. Bartfai. (2000). Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. U.S.A., 97(21):11534-11539.
92. Vezzani, A., S. Balosso, T. Ravizza. (2008). The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun., 22(6):797-803.
93. Viviani, B., S. Bartesaghi, F. Gardoni, A. Vezzani, M.M. Behrens, T. Bartfai, M. Binaglia, E. Corsini, M. Di Luca, C.L. Galli, M. Marinovich. (2003). Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci., 23(25):8692-8700.
94. Viviani, B., F. Gardoni, M. Marinovich. (2007). Cytokines and neuronal ion channels in health and disease. Int. Rev. Neurobiol., 82:247-263.
95. Voutsinos-Porche, B., E. Koning, H. Kaplan, A. Ferrandon, M. Guenounou, A. Nehlig, J. Motte. (2004). Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol. Dis., 17(3):385-402.
96. Wang, S., Q. Cheng, S. Malik, J. Yang. (2000). Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J. Pharmacol. Exp. Ther., 292(2):497-504.
97. Wiedmer, T., P.J. Sims. (1985). Effect of complement proteins C5b-9 on blood platelets: evidence for reversible depolarization of membrane potential. J. Biol. Chem., 260(13):8014-8019.
98. Willingale, H.L., N.J. Gardiner, N. McLymont, S. Giblett, B.D. Grubb. (1997). Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br. J. Pharmacol., 122(8):1593-1604.
99. Wolfe, L.S., O.A. Mamer. (1975). Measurement of prostaglandin F2alpha levels in human cerebrospinal fluid in normal and pathological conditions. Prostaglandins, 9(2):183-192.
100. Xiong, Z.Q., W. Qian, K. Suzuki, J.O. McNamara. (2003). Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J. Neurosci., 23(3):955-960.
101. Yamagata, K., K.I. Andreasson, W.E. Kaufmann, C.A. Barnes, P.F. Worley. (1993). Expression of a mitogeninducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron, 11(2):371-386.
102. Zeise, M.L., J. Espinoza, P. Morales, A. Nalli. (1997). Interleukin-1beta does not increase synaptic inhibition in hippocampal CA3 pyramidal and dentate gyrus granule cells of the rat in vitro. Brain Res., 768(1-2):341-344.